Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach

被引:2
作者
Mathew, Shibu [1 ]
Saguner, Ardan M. [1 ,2 ]
Schenker, Niklas [1 ]
Kaiser, Lukas [1 ]
Zhang, Pengpai [1 ]
Yashuiro, Yoshiga [1 ]
Lemes, Christine [1 ]
Fink, Thomas [1 ]
Maurer, Tilman [1 ]
Santoro, Francesco [1 ]
Wohlmuth, Peter [1 ]
Reissmann, Bruno [1 ]
Heeger, Christian H. [3 ]
Tilz, Roland [3 ]
Wissner, Erik [4 ]
Rillig, Andreas [1 ]
Metzner, Andreas [1 ]
Kuck, Karl-Heinz [1 ]
Ouyang, Feifan [1 ]
机构
[1] Asklepios Klin St Georg, Dept Cardiol, Lohmuhlenstr 5, D-20099 Hamburg, Germany
[2] Univ Heart Ctr, Dept Cardiol, Zurich, Switzerland
[3] Univ Hosp Schleswig Holstein, Univ Heart Ctr Lubeck, Med Clin 2, Lubeck, Germany
[4] Univ Illinois, Coll Med, Chicago, IL USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 05期
关键词
arrhythmogenic right ventricular dysplasia/cardiomyopathy; catheter ablation; epicardial ablation; ventricular tachycardia; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; EPICARDIAL SUBSTRATE; ENDOCARDIAL ABLATION; OUTCOMES; DYSPLASIA/CARDIOMYOPATHY; TERM; RECURRENCE; DISEASE; THERAPY; DEATH;
D O I
10.1161/JAHA.118.01036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-It has been suggested that endocardial and epicardial ablation of ventricular tachycardia (VT) improves outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia. We investigated our sequential approach for VT ablation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia in a single center. Methods and Results-We included 47 patients (44 +/- 16 years) with definite (81%) or borderline (19%) arrhythmogenic right ventricular cardiomyopathy/dysplasia between 1998 and 2016. Our ablation strategy was to target the endocardial substrate. Epicardial ablation was performed in case of acute ablation failure or lack of an endocardial substrate. Single and multiple procedural 1- and 5-year outcome data for the first occurrence of the study end points (sustained VT/ventricular fibrillation, heart transplant, and death after the index procedure, and sustained VT/ventricular fibrillation for multiple procedures) are reported. Eighty-one radiofrequency ablation procedures were performed (mean 1.7 per patient, range 1-4). Forty-five (56%) ablation procedures were performed via an endocardial, 11 (13%) via an epicardial, and 25 (31%) via a combined endo- and epicardial approach. Complete acute success was achieved in 65 (80%) procedures, and partial success in 13 (16%). After a median follow-up of 50.8 (interquartile range, [18.6; 99.2]) months after the index procedure, 17 (36%) patients were free from the primary end point. After multiple procedures, freedom from sustained VT/ventricular fibrillation was 63% (95% CI, 52-75) at 1 year, and 45% (95% CI, 34-61) at 5 years, with 36% of patients receiving only endocardial radiofrequency ablation. A trend (log rank P=0.058) towards an improved outcome using a combined endo-/epicardial approach was observed after multiple procedures. Conclusion-Endocardial ablation can be effective in a considerable number of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with VT, potentially obviating the need for an epicardial approach.
引用
收藏
页数:13
相关论文
共 36 条
[1]   Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Arrhythmia-Free Survival After Endo-Epicardial Substrate Based Mapping and Ablation [J].
Bai, Rong ;
Di Biase, Luigi ;
Shivkumar, Kalyanam ;
Mohanty, Prasant ;
Tung, Roderick ;
Santangeli, Pasquale ;
Carlos Saenz, Luis ;
Vacca, Miguel ;
Verma, Atul ;
Khaykin, Yariv ;
Mohanty, Sanghamitra ;
Burkhardt, J. David ;
Hongo, Richard ;
Beheiry, Salwa ;
Dello Russo, Antonio ;
Casella, Michela ;
Pelargonio, Gemma ;
Santarelli, Pietro ;
Sanchez, Javier ;
Tondo, Claudio ;
Natale, Andrea .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2011, 4 (04) :478-485
[2]   Arrhythmogenic right ventricular cardiomyopathy [J].
Basso, Cristina ;
Corrado, Domenico ;
Marcus, Frank I. ;
Nava, Andrea ;
Thiene, Gaetano .
LANCET, 2009, 373 (9671) :1289-1300
[3]   Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study [J].
Berruezo, Antonio ;
Acosta, Juan ;
Fernandez-Armenta, Juan ;
Pedrote, Alonso ;
Barrera, Alberto ;
Arana-Rueda, Eduardo ;
Ignacio Bodegas, Andres ;
Anguera, Ignasi ;
Tercedor, Luis ;
Penela, Diego ;
Andreu, David ;
Jesus Perea, Rosario ;
Prat-Gonzalez, Susana ;
Mont, Lluis .
EUROPACE, 2017, 19 (04) :607-616
[4]   Combined Endocardial and Epicardial Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia Incorporating Scar Dechanneling Technique [J].
Berruezo, Antonio ;
Fernandez-Armenta, Juan ;
Mont, Lluis ;
Zeljko, Hrvojka ;
Andreu, David ;
Herczku, Csaba ;
Boussy, Tim ;
Maria Tolosana, Jose ;
Arbelo, Elena ;
Brugada, Josep .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (01) :111-121
[5]   VT Recurrence After Ablation: Incomplete Ablation or Disease Progression? A Multicentric European Study [J].
Berte, B. ;
Sacher, F. ;
Venlet, J. ;
Andreu, D. ;
Mahida, S. ;
Aldhoon, B. ;
De Potter, T. ;
Sarkozy, A. ;
Tavernier, R. ;
Andronache, M. ;
Deneke, T. ;
Kautzner, J. ;
Berruezo, A. ;
Cochet, H. ;
Zeppenfeld, K. ;
Jais, Pierre .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (01) :80-87
[6]   Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium - Are they different diseases? [J].
Burke, AP ;
Farb, A ;
Tashko, G ;
Virmani, R .
CIRCULATION, 1998, 97 (16) :1571-1580
[7]   Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with Arrhythmogenic right ventricular cardiomyopathy/dysplasia [J].
Corrado, D ;
Leoni, L ;
Link, MS ;
Della Bella, P ;
Gaita, F ;
Curnis, A ;
Salerno, JU ;
Igidbashian, D ;
Raviele, A ;
Disertori, M ;
Zanotto, G ;
Verlato, R ;
Vergara, G ;
Delise, P ;
Turrini, P ;
Basso, C ;
Naccarella, F ;
Maddalena, F ;
Estes, NAM ;
Buja, G ;
Thiene, G .
CIRCULATION, 2003, 108 (25) :3084-3091
[8]   Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement [J].
Corrado, Domenico ;
Wichter, Thomas ;
Link, Mark S. ;
Hauer, Richard ;
Marchlinski, Frank ;
Anastasakis, Aris ;
Bauce, Barbara ;
Basso, Cristina ;
Brunckhorst, Corinna ;
Tsatsopoulou, Adalena ;
Tandri, Harikrishna ;
Paul, Matthias ;
Schmied, Christian ;
Pelliccia, Antonio ;
Duru, Firat ;
Protonotarios, Nikos ;
Estes, N. A. Mark, III ;
McKenna, William J. ;
Thiene, Gaetano ;
Marcus, Frank I. ;
Calkins, Hugh .
EUROPEAN HEART JOURNAL, 2015, 36 (46) :3227-3237
[9]   Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia [J].
Corrado, Domenico ;
Calkins, Hugh ;
Link, Mark S. ;
Leoni, Loira ;
Favale, Stefano ;
Bevilacqua, Michela ;
Basso, Cristina ;
Ward, Deirdre ;
Boriani, Giuseppe ;
Ricci, Renato ;
Piccini, Jonathan P. ;
Dalal, Darshan ;
Santini, Massimo ;
Buja, Gianfranco ;
Iliceto, Sabino ;
Estes, N. A. Mark, III ;
Wichter, Thomas ;
McKenna, William J. ;
Thiene, Gaetano ;
Marcus, Frank I. .
CIRCULATION, 2010, 122 (12) :1144-1152
[10]   Long-term efficacy of catheter ablation of ventricular tachycardia in patients with Arrhythmogenic right ventricular dysplasia/cardiomyopathy [J].
Dalal, Darshan ;
Jain, Rahul ;
Tandri, Harikrishna ;
Dong, Jun ;
Eid, Shaker M. ;
Prakasa, Kalpana ;
Tichnell, Crystal ;
James, Cynthia ;
Abraham, Theodore ;
Russell, Stuart D. ;
Sinha, Sunil ;
Judge, Daniel P. ;
Bluemke, David A. ;
Marine, Joseph E. ;
Calkins, Hugh .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (05) :432-440